Nexstim announces the result of its private placement

on 17/12/2015 11:04

Additional data confirm positive results for Clinical Trial of ReActiv8®

on 04/12/2015 10:24
Additional data confirm clinically important, statistically significant, and lasting improvement in pain, disability, and quality of life for people with Chronic Low Back Pain and limited treatment options
Read more

Nexstim Plc announces completion of enrolment of Phase III Clinical Trial in Stroke Therapy

on 03/12/2015 10:27
Recruitment completed ahead of schedule
Read more

Mainstay Medical – Interim Management Statement

on 09/11/2015 11:45

Mainstay Medical Applies for CE Mark for ReActiv8®

on 02/11/2015 11:38
A key step towards European commercialisation of innovative treatment of chronic low back pain
Read more